Real-World Treatment Patterns and Clinical Outcomes Among Patients with Metastatic or Unresectable EGFR-Mutated Non-Small Cell Lung Cancer Previously Treated with Osimertinib and Platinum-Based Chemotherapy.
Jyoti D PatelJie MengHoa LeYoko TanakaSudarshan PhaniMaribel SalasChuntao WuDavid SternbergStephen EskerJeffrey P AndersonAaron CrowleySummera Q ZhouCamryn LiebHaiyan SunQuan V DoanAnu SanthanagopalKaren L ReckampPublished in: Advances in therapy (2024)
The treatment landscape for this heavily pretreated population of patients with EGFRm mNSCLC is fragmented, with no uniformly accepted standard of care. A high unmet need exists for therapeutic options that provide meaningful improvements in clinical benefit.